Is InfuSystem Holdings, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for InfuSystem Holdings, Inc. has moved from fair to very expensive, indicating that the stock is overvalued. The company exhibits a P/E ratio of 47, a Price to Book Value of 2.71, and an EV to EBITDA of 8.31, all of which suggest a premium valuation compared to its peers. For instance, Lincoln Educational Services Corp. has a P/E of 59.63, while TaskUs, Inc. stands at a much lower P/E of 27.32, highlighting the relative overvaluation of InfuSystem.
The stock has shown mixed performance against the S&P 500, with a year-to-date return of 6.51% compared to the index's 13.30%, and a significant decline of 31.19% over the past five years, while the S&P 500 has gained 91.29% during the same period. This performance further reinforces the notion that InfuSystem Holdings, Inc. is currently overvalued in the market.